Skip to content

Released Aug 5, 2021, before the open

10-Q filed Aug 5, 2021, 36 days after period end · 0001493152-21-018675

Q2 2021 · 10-Q
Revenue—
Net Income-$6.81MN/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.08N/M vs Q2 2020N/M vs Q1 2021
Operating Income-$2,990,279N/M
Operating Cash Flowderived-$2,363,282N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2021Q2 2020Q2 2019Q2 2018
Revenue——$0.00$0.00
Net Income-$6.81M-$6.37M-$3.43M-$3.26M
EPS Diluted-$0.08-$0.13-$0.14-$0.15

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR